247 related articles for article (PubMed ID: 29113770)
1. Pathologic Predictors of Survival During Lymph Node Dissection for Metastatic Renal-Cell Carcinoma: Results From a Multicenter Collaboration.
Chipollini J; Abel EJ; Peyton CC; Boulware DC; Karam JA; Margulis V; Master VA; Zargar-Shoshtari K; Matin SF; Sexton WJ; Raman JD; Wood CG; Spiess PE
Clin Genitourin Cancer; 2018 Apr; 16(2):e443-e450. PubMed ID: 29113770
[TBL] [Abstract][Full Text] [Related]
2. Overall survival in patients with metastatic renal cell carcinoma and clinical N1 disease undergoing cytoreductive nephrectomy and lymph node dissection.
Faiena I; Salmasi A; Lenis AT; Donin NM; Johnson DC; Bachour K; Drakaki A; Belldegrun AS; Pantuck AJ; Chamie K
Urol Oncol; 2018 Feb; 36(2):79.e19-79.e26. PubMed ID: 29103965
[TBL] [Abstract][Full Text] [Related]
3. Radical Nephrectomy With or Without Lymph Node Dissection for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-based Analysis.
Gershman B; Thompson RH; Moreira DM; Boorjian SA; Tollefson MK; Lohse CM; Costello BA; Cheville JC; Leibovich BC
Eur Urol; 2017 Apr; 71(4):560-567. PubMed ID: 27671144
[TBL] [Abstract][Full Text] [Related]
4. Lymph Node Dissection is Not Associated with Improved Survival among Patients Undergoing Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: A Propensity Score Based Analysis.
Gershman B; Thompson RH; Moreira DM; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
J Urol; 2017 Mar; 197(3 Pt 1):574-579. PubMed ID: 27663461
[TBL] [Abstract][Full Text] [Related]
5. The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT
Marchioni M; Bandini M; Pompe RS; Martel T; Tian Z; Shariat SF; Kapoor A; Cindolo L; Briganti A; Schips L; Capitanio U; Karakiewicz PI
BJU Int; 2018 Mar; 121(3):383-392. PubMed ID: 28940649
[TBL] [Abstract][Full Text] [Related]
6. Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC).
Tilki D; Chandrasekar T; Capitanio U; Ciancio G; Daneshmand S; Gontero P; Gonzalez J; Haferkamp A; Hohenfellner M; Huang WC; Linares Espinós E; Lorentz A; Martinez-Salamanca JI; Master VA; McKiernan JM; Montorsi F; Novara G; Pahernik S; Palou J; Pruthi RS; Rodriguez-Faba O; Russo P; Scherr DS; Shariat SF; Spahn M; Terrone C; Vera-Donoso C; Zigeuner R; Libertino JA; Evans CP
Urol Oncol; 2018 Feb; 36(2):79.e11-79.e17. PubMed ID: 29129353
[TBL] [Abstract][Full Text] [Related]
7. Emulating Target Clinical Trials of Radical Nephrectomy With or Without Lymph Node Dissection for Renal Cell Carcinoma.
Bacic J; Liu T; Thompson RH; Boorjian SA; Leibovich BC; Golijanin D; Gershman B
Urology; 2020 Jun; 140():98-106. PubMed ID: 32142726
[TBL] [Abstract][Full Text] [Related]
8. Extent of lymph node dissection improves overall survival in pT3N0 non-metastatic renal cell carcinoma patients treated with radical nephrectomy: a propensity score-based analysis.
Wei Y; Wang M; Jin Y; Zhou C; Lyu J
World J Urol; 2020 Jun; 38(6):1579-1585. PubMed ID: 31065795
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and Prognostic Significance of Radiologic Node-positive Renal Cell Carcinoma in the Absence of Distant Metastases: A Retrospective Analysis of Patients Undergoing Nephrectomy and Lymph Node Dissection.
Lee HW; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
J Korean Med Sci; 2015 Sep; 30(9):1321-7. PubMed ID: 26339174
[TBL] [Abstract][Full Text] [Related]
10. Lymph node dissection during radical nephrectomy: A Canadian multi-institutional analysis.
Kokorovic A; Breau RH; Kapoor A; Finelli A; So AI; Lavallee LT; Tanguay S; Pouliot F; Drachenberg DE; Fairey A; Lattouf JB; Kawakami J; Wood L; Mallick R; Rendon RA
Urol Oncol; 2021 Jun; 39(6):371.e17-371.e25. PubMed ID: 33785219
[TBL] [Abstract][Full Text] [Related]
11. Lymph node dissection during cytoreductive nephrectomy: a retrospective analysis.
Feuerstein MA; Kent M; Bernstein M; Russo P
Int J Urol; 2014 Sep; 21(9):874-9. PubMed ID: 24712686
[TBL] [Abstract][Full Text] [Related]
12. Extent of lymphadenectomy does not improve the survival of patients with renal cell carcinoma and nodal metastases: biases associated with the handling of missing data.
Sun M; Trinh QD; Bianchi M; Hansen J; Abdollah F; Tian Z; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
BJU Int; 2014 Jan; 113(1):36-42. PubMed ID: 23490031
[TBL] [Abstract][Full Text] [Related]
13. Influence of lymph node dissection in patients undergoing radical nephrectomy for non-metastatic renal cell carcinoma: a systematic review and meta-analysis.
Luo X; Li JX; Liu YT; Zou G; Yao WX; Qing GQ; Yang RL; Ye XY; Facchini G; Rossetti S
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6079-6090. PubMed ID: 31364109
[TBL] [Abstract][Full Text] [Related]
14. Extent of lymph node dissection at nephrectomy affects cancer-specific survival and metastatic progression in specific sub-categories of patients with renal cell carcinoma (RCC).
Capitanio U; Suardi N; Matloob R; Roscigno M; Abdollah F; Di Trapani E; Moschini M; Gallina A; Salonia A; Briganti A; Montorsi F; Bertini R
BJU Int; 2014 Aug; 114(2):210-5. PubMed ID: 24854206
[TBL] [Abstract][Full Text] [Related]
15. Preoperative predictors of pathological lymph node metastasis in patients with renal cell carcinoma undergoing retroperitoneal lymph node dissection.
Babaian KN; Kim DY; Kenney PA; Wood CG; Wong J; Sanchez C; Fang JE; Gerber JA; Didic A; Wahab A; Golla V; Torres C; Tamboli P; Qiao W; Matin SF; Wood CG; Karam JA
J Urol; 2015 Apr; 193(4):1101-7. PubMed ID: 25390078
[TBL] [Abstract][Full Text] [Related]
16. Analysis of lymph node dissection in patients with ≥7-cm renal tumors.
Feuerstein MA; Kent M; Bazzi WM; Bernstein M; Russo P
World J Urol; 2014 Dec; 32(6):1531-6. PubMed ID: 24402173
[TBL] [Abstract][Full Text] [Related]
17. Oncologic Outcomes of Cytoreductive Nephrectomy in Synchronous Metastatic Renal-Cell Carcinoma: A Single-Center Experience.
Choi CI; Kang M; Sung HH; Jeon HG; Jeong BC; Jeon SS; Lee HM; Seo SIL
Clin Genitourin Cancer; 2018 Dec; 16(6):e1189-e1199. PubMed ID: 30262447
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of clinical nodal staging and factors associated with receipt of lymph node dissection at the time of surgery for nonmetastatic renal cell carcinoma.
Radadia KD; Rivera-Núñez Z; Kim S; Farber NJ; Sterling J; Falkiewicz M; Modi PK; Goyal S; Parikh R; Weiss RE; Kim IY; Elsamra SE; Jang TL; Singer EA
Urol Oncol; 2019 Sep; 37(9):577.e17-577.e25. PubMed ID: 31280982
[TBL] [Abstract][Full Text] [Related]
19. Lymph node density for stratification of survival outcomes with node positive upper tract urothelial carcinoma.
Raza SJ; Miller C; May A; Davaro F; Siddiqui SA; Hamilton Z
Can J Urol; 2019 Aug; 26(4):9852-9858. PubMed ID: 31469641
[TBL] [Abstract][Full Text] [Related]
20. The extent of lymphadenectomy does affect cancer specific survival in pathologically confirmed T4 renal cell carcinoma.
Capitanio U; Matloob R; Suardi N; Abdollah F; Castiglione F; Di Trapani D; Russo A; Briganti A; Carenzi C; Salonia A; Montorsi F; Rigatti P; Bertini R
Urologia; 2012; 79(2):109-15. PubMed ID: 22610843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
